Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Bullboard Posts
Comment by Sniper007on Apr 17, 2014 6:55pm
143 Views
Post# 22465994

RE:RE:Irked

RE:RE:IrkedI agree KayakerBC that successful phase I and Phase II studies would do wonders for the stock but when it that going to happen? New licensing deals, however, may be non-disclosure dollar deals much like the Medimmune deal which leaves us in the dark and our sp in the crapper. Medimmune, rightly so, does not want to give anything to the other pharmas in terms of what they may or may not be paying but it could be huge dollars for all we know. BTI has not yet publicly decided what direction they're taking BT2111 but it doesn't look like they'll be going it alone if they do move it forward. Because they haven't given any indication whatsoever, it says to me they may have something already in the hopper related to that. That said, I find it difficult to visualize BTI having a sp anywhere near GEVA in the short term or mid term the way it's going right now and it is this forum alone that "believes" extraordinary share price increases are indeed possible. I'm beginning to doubt it, unfortunately. Maybe I'm just losing my patience with this company right now. Hold our nose, cross our fingers and wait, right? Hopefully Jd's prediction that something significant happens in 2-3 weeks materializes. Happy Easter all. Sniper
Bullboard Posts